How can a 60-year-old male treat NSCLC?

Question

Hello doctor,

My husband is 60 and was diagnosed with non-small cell lung cancer three months ago. All mutation tests, including EGFR, ALK, and ROS1, came back negative, and now we are confused about the way forward.

Can a 60-year-old lung cancer patient with no mutations still respond to immunotherapy, or is chemotherapy the only remaining option for him?
He has been relatively healthy otherwise, with no major pre-existing conditions, and we feel he deserves every chance at a good treatment response. Should we be seeking a second opinion from another oncologist or requesting additional tests before finalizing the plan?

Please advise us at the earliest.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I have gone through your query and understand your concern.

I understand how uncertain this phase feels, especially when the common mutation reports (attachments were removed to protect patient identity) have come back negative.

I will explain this clearly. Even without EGFR (epidermal growth factor receptor), ALK (anaplastic lymphoma kinase), or ROS1 (proto-oncogene 1) mutations, your husband still has very effective treatment options. In such cases, immunotherapy (treatment that uses the body's immune system, usually your own, to attack cancer) plays a major role. Many patients without these mutations respond well to immunotherapy, either alone or along with chemotherapy.

The next important factor that guides treatment is the PD-L1 (programmed-death ligand) level. If this is high, doctors may choose immunotherapy alone. If it is lower, a combination of chemotherapy and immunotherapy is commonly used. So chemotherapy is not the only remaining option, and in many cases, it is combined with immunotherapy rather than given alone.

Since your husband is otherwise healthy, that works in his favor. Patients with good general condition usually tolerate treatment better and have a better response overall.

If PD-L1 testing has not been done yet, it is important to check that before finalizing the treatment plan. In some cases, broader testing may also be considered, but PD-L1 is the key next step.

Taking a second opinion is absolutely reasonable. It can help you feel more confident about the plan and ensure that all appropriate options have been considered. It does not usually delay treatment if done quickly.

I hope I have answered your question.

Let me know if I can assist you further.

Thank you.